Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • danwiththeplan
    Member
    • Sep 2011
    • 72

    #1

    QIIME constraints and time to run for 16S Illumina

    Hi, I am looking to help analyse a dataset that consists of a number of 16S (V3-V4) amplicons sequenced on a MiSeq (in triplicate) from a number of data points, with a view to getting the relative abundances of OTUs in the samples.
    I was wondering a few things:
    1) Are there any memory and / or processor-speed constraints when running QIIME, i.e. can you run every step in the pipeline on a reasonably good desktop (i7) with reasonable memory (8GB) in a reasonable time, or do you need to start using clusters or high-memory computers?
    2)Any estimates on how long (for example) it would take to run a simple comparison between sample A and sample B (triplicated) to get relative abundances of OTUs and the appropriate pretty graphs?
    3) Are there any common stumbling blocks that people tend to encounter, either in the setup or the running? I have already set it up natively on Ubuntu 12.04 LTS with only a few problems, and I understand the VDIs are good too.

    Any help or feedback appreciated. Cross-posted in "Metagenomics" since I'm not sure which is the most appropriate forum.

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Yesterday, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
28 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
71 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...